Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas
Abstract Background This long-term retrospective analysis aimed to investigate the outcome and toxicity profile of stereotactic brachytherapy (SBT) in selected low-grade gliomas WHO grade II (LGGII) in a large patient series. Methods This analysis comprised 106 consecutive patients who received SBT...
Main Authors: | Juliana Watson, Alexander Romagna, Hendrik Ballhausen, Maximilian Niyazi, Stefanie Lietke, Sebastian Siller, Claus Belka, Niklas Thon, Silke Birgit Nachbichler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-020-01719-9 |
Similar Items
-
Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01) -
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
by: Congxiao Wang, et al.
Published: (2020-06-01) -
Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
by: Indrawati Hadi, et al.
Published: (2021-02-01) -
Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
by: Congxiao Wang, et al.
Published: (2022-04-01) -
Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
by: Ruge Maximilian I, et al.
Published: (2012-06-01)